SYDNEY (Reuters) - Australia's medical regulator said on Tuesday it had granted provisional approval for the COVID-19 vaccine developed by AstraZeneca, making it the second vaccine to get regulatory approval in Australia.
The regulator last month approved the Pfizer-BioNTech COVID-19 vaccine for use and inoculations for its 25 million population will begin from Feb. 22.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!